[18F]UCB-2897

N/A

Report date: 2025/09/24 14:01:35

NME

Base Information

Drug Name[18F]UCB-2897

Drug Alias NameUCB-2897[18F]UCB-2897

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionSynuclein alpha modulatorsIonising radiation emitters

TargetsSynuclein alpha

Therapy Area/IndicationsParkinson DiseaseMultiple System Atrophy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesInvicro Llc

China Registration ClassN/A

Develop Information

Active CompaniesInvicro Llc

Inactive CompaniesN/A

Active IndicationsParkinson DiseaseMultiple System Atrophy

Inactive IndicationsN/A

Other Information

ATC CodeN/A